Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001382963-18-000131)

Filing Details

Accession Number:: 0001382963-18-000131
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2018-09-19 14:19:26
Reporting Period:: 2018-08-17

Accepted Time:: 2018-09-19 14:19:26
Original Submission Date:: 2018-08-20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1460702	Ritter Pharmaceuticals Inc	RTTR	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1237556	W Matthew Foehr	Ritter Pharmaceuticals, Inc. 1880 Century Park East, Suite 1000 Los Angeles, CA 90067		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-08-17	19,751	$2.04	23,251	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The previous Form 4 filed on August 20, 2018 did not reflect the Issuer's recent reverse stock split and inadvertently overstated the amount of securities beneficially owned by the Reporting Person following the reported transaction. The number included here has been updated to reflect such reverse stock split.